CraniUS Featured in The Baltimore Sun
CraniUS Awarded $1 million Grant from the State of Maryland
CraniUS Named Company of the Year: Top Medtech Start-up 2023 by Medtech Outlook
Refillable Device for Drug Delivery Past the Blood-Brain Barrier: Interview with Mike Maglin, CEO at CraniUS
Interview with Michael Maglin, CEO of CraniUS
CraniUS Closes ~$20 Million Series A Funding Round
The NeuroPass device is currently in the pre-clinical development stage and is not yet commercially available. It is on the pathway to clinical studies, and any information provided is subject to change as research progresses.
CAUTION: Investigational Device. Limited by Federal (or United States) law to investigational use.
© Copyright 2024 | CraniUS
